|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2003-10-6
|
|
pubmed:abstractText |
For locally advanced and nonresectable cancer of the pancreas, we performed intra-arterial infusion chemotherapy with angiotensin-II (AT-II). In our preliminary report, this treatment resulted in a median of 14 months of survival without objective adverse effects. This study was designed to clarify the prognostic factor in this chemotherapy by using a larger number of cases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
927-34
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14527913-Adenocarcinoma,
pubmed-meshheading:14527913-Adult,
pubmed-meshheading:14527913-Aged,
pubmed-meshheading:14527913-Angiotensin II,
pubmed-meshheading:14527913-Chi-Square Distribution,
pubmed-meshheading:14527913-Female,
pubmed-meshheading:14527913-Humans,
pubmed-meshheading:14527913-Infusions, Intra-Arterial,
pubmed-meshheading:14527913-Male,
pubmed-meshheading:14527913-Methotrexate,
pubmed-meshheading:14527913-Middle Aged,
pubmed-meshheading:14527913-Pancreatic Neoplasms,
pubmed-meshheading:14527913-Prognosis,
pubmed-meshheading:14527913-Statistics, Nonparametric,
pubmed-meshheading:14527913-Survival Analysis,
pubmed-meshheading:14527913-Vasoconstrictor Agents
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Intra-arterial infusion chemotherapy with angiotensin-II for locally advanced and nonresectable pancreatic adenocarcinoma: further evaluation and prognostic implications.
|
|
pubmed:affiliation |
Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. oohigasi-hi@mc.pref.osaka.jp
|
|
pubmed:publicationType |
Journal Article
|
